Research facility · founded 1898
Roswell Park Comprehensive Cancer Center
Buffalo, United States · roswellpark.org
- Citations, last 5 years
- 77.5k
- Works, last 5 years
- 6 260
- h-index
- 729
- Scientists listed
- 671
- Grants since 2016
- 750
Grants received
2016–2022 · research · R01
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · fellowship · F99
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
Hayley Affronti · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · research · R21
Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit
Maansi Bansal-Travers · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R50
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2022 · research · R01
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R50
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2019 · research · R03
Genes determining sensitivity to oxygen and nutrient deprivation
Eugene S Kandel · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2020 · research · R21
Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit
Maansi Bansal-Travers · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · research · R03
Genes determining sensitivity to oxygen and nutrient deprivation
Eugene S Kandel · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R50
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2022 · research · R01
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2029 · research · R35
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
David Guy Kirsch · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2029 · research · R35
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
David Guy Kirsch · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2020 · research · R01
Non-invasive assessment of salivary gland function: Translational Studies
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · fellowship · F99
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
Hayley Affronti · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2017 · research · R21
Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses
Xuefang Cao · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2027 · research · R50
Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Non-invasive assessment of salivary gland function: Translational Studies
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2019 · research · R21
Novel intervention to increase lactation practices by African American Women
Deborah O Erwin · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2027 · research · R50
Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2020 · research · R01
Non-invasive assessment of salivary gland function: Translational Studies
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2017 · research · R21
Novel Mouse Models to define Genetic Drivers of Aggressive Prostate Cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R50
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R50
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
Hans Minderman · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · research · R21
Novel intervention to increase lactation practices by African American Women
Deborah O Erwin · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016 · career development · K07
mTOR pathway in breast cancer subtypes by race: A molecular pathological study
Ting-Yuan Cheng · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer
Leigh Ellis · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2018 · research · R21
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer
James L Mohler · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
Dominic James Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
